Regarding the higher score of the IMMUNE1 gene module, we found it associated with good prognosis in ER+/HER2− subtype and across all breast cancer subtypes and even tended to be associated with less tamoxifen effect. This evidence concerns the gene ESR1 and breast carcinoma.